| Primary information |
|---|
| ID | 16548 |
| Uniprot ID | P85776 |
| Description | Callisulfakinin [Cleaved into- Callisulfakinin-1 (Callisulfakinin I); Callisulfakinin-2 (Callisulfakinin II)] |
| Organism | Supella dimidiata |
| Txonomy | Calliphora ; Calliphorinae ; Calliphoridae ; Oestroidea ; Calyptratae ; Schizophora ; Cyclorrhapha ; Eremoneura ; Muscomorpha ; Brachycera ; Diptera ; Endopterygota (cohort); Neoptera (infraclass); Pterygota (subclass); Dicondylia ; Insecta ; Hexapoda ; Pancrustacea ; Mandibulata ; Arthropoda ; Panarthropoda ; Ecdysozoa ; Protostomia ; Bilateria ; Eumetazoa ; Metazoa ; Opisthokonta ; Eukaryota ; cellular organisms |
| Subcellular Location | secreted |
| Developmental Stage | NA |
| Similarity | Periviscerokinin family |
| Tissue Specificity | In brain; it is specifically expressed in four pairs of neurons. Not expressed in other cells of the brain and in the thoracico-abdominal ganglion. |
| Post Translational Modification | T11 Valine amide |
| Function | Myotropic activity |
| Length | 140 |
| Molecular Weight | 16 |
| Name | Periviscerokinin-3 |
| Sequence | GSSGMIPFPRV |
| Sequence map | NA |
| PDB ID | NA |
| Drugpedia | NA |
| Receptor | NA |
| Domain | NA |
| Pharmaceutical Use | NA
|